Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0R6Y stock hub

LON/0R6Y has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R6Yis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

126.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R6Y

In the news

Latest news · LON/0R6Y

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-14.6

P25 n/aP50 n/aP75 n/a

ROIC-9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R6Y market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

NOK

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	UK
Employees	18
Employees Change	9%
Employees Change Percent	100
Enterprise value	NOK 126.1M
Exchange	London Stock Exchange
Financial currency	NOK
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	NO0010597883
Last refreshed	2026-05-10
Market cap	NOK 126.9M
Price	NOK 4.46
Price currency	NOK
Rev Per Employee	3,435.5x
Sic	2836
Symbol	lon/0R6Y
Website	https://www.thormedical.no

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.37%
EV Earnings	-29.5x
EV/FCF	-14.18x
FCF yield	-7.01%
P/B ratio	3.77x
P/S ratio	2,051.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	NOK 61,839
Gross Profit Growth	739%
Net Income	NOK -4.3M
Pretax Margin	-7,421.66%
Profit Per Employee	NOK -237,544
ROA	-7.75
ROCE	-10.47
ROE	-14.63
ROIC	-9.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	76.6%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NOK 0
Assets	NOK 52.2M
Cash	NOK 13.3M
Current Assets	NOK 15.9M
Current Liabilities	NOK 3.5M
Debt	NOK 12.6M
Debt Equity	NOK 0.38
Debt FCF	NOK -1.42
Equity	NOK 33.6M
Interest Coverage	-115.7
Liabilities	NOK 18.6M
Long Term Assets	NOK 36.3M
Long Term Liabilities	NOK 15.1M
Net Cash	NOK 676,393
Net Cash By Market Cap	NOK 0.53
Net Cash Growth	-92.52%
Net Debt Equity	NOK -0.02
Tangible Book Value	NOK 14.1M
Tangible Book Value Per Share	NOK 0.04
WACC	2.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.57
Net Working Capital	NOK -923,085
Quick ratio	4.46
Working Capital	NOK 11.5M
Working Capital Turnover	NOK 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	76.54%
200-day SMA	4.11
50-day SMA	4.66
50-day SMA vs 200-day SMA	50over200
All Time High	5.67
All Time High Change	-21.38%
All Time High Date	2026-04-10
All Time Low	0.87
All Time Low Change	410.3%
All Time Low Date	2024-03-06
ATR	0.17
Beta	-0.3
Ch YTD	-14.28
High	4.46
High52	5.67
High52 Date	2026-04-10
High52ch	-21.38%
Low	4.39
Low52	2.29
Low52 Date	2025-06-04
Low52ch	94.4%
Ma50ch	-4.35%
Price vs 200-day SMA	8.56%
RSI	43.11
RSI Monthly	64.93
RSI Weekly	50.75
Sharpe ratio	1.23x
Sortino ratio	2.04
Total Return	-40.8%
Tr YTD	-14.28
Tr1m	-9.31%
Tr1w	-1.38%
Tr3m	-6.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK -5.1M
Operating margin	-8,301.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	152,853,246%
Net Borrowing	-85,861.9
Shares Insiders	8.6%
Shares Institutions	8.53%
Shares Qo Q	13.99%
Shares Yo Y	40.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NOK -9.2M
Average Volume	13,768.35x
Bv Per Share	0.09
CAPEX	NOK -5.4M
Ch1m	-9.31
Ch1w	-1.38
Ch1y	76.54
Ch3m	-6.36
Ch6m	21.46
Change	-0.72%
Change From Open	-0.67
Close	4.49
Days Gap	-0.06
Depreciation Amortization	1,554,913
Dollar Volume	51,658
Earnings Date	2026-08-28
EBIT	NOK -5.1M
EBITDA	NOK -3.7M
EPS	NOK -0.01
F Score	1
FCF	NOK -8.9M
FCF EV Yield	-7.05x
Financing CF	12,617,311
Fiscal Year End	December
Founded	2,009
Goodwill	2,964,227.1
Income Tax	NOK -313,690
Investing CF	-4,899,853
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Ma150	4.42
Ma150ch	0.85%
Ma20	4.81
Ma20ch	-7.23%
Net CF	4,213,509
Next Earnings Date	2026-08-28
Open	4.49
Position In Range	100
Ppne	19,452,661
Price Date	2026-05-08
Ptbv Ratio	8.97
Relative Volume	0.84x
Revenue	61,839x
SBC By Revenue	477.59x
Share Based Comp	295,337
Tax By Revenue	-507.27x
Tr6m	21.46%
Volume	11,589
Z Score	2.06

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0R6Y pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0R6Y stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R6Y?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.5%

Share of float held by funds and institutions

Insider ownership

+8.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+40.8%

Negative means the company is buying back shares.

Technical

LON/0R6Y momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.1

Neutral momentum band

Price vs 200-day MA

+8.6%

50/200-day relationship not available

Beta (5Y)

-0.30

Less volatile than the market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R6Y

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R6Y stock rating?

lon/0R6Y is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R6Y analysis?

The full report lives at /stocks/lon/0R6Y/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R6Y?

The latest report frames lon/0R6Y around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R6Y page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.